FDA Releases New Draft Guidances on Gene Therapies

Drug Industry Daily
A A
The FDA unveiled six new draft guidances outlining its latest thinking on the rapidly evolving field of gene therapy — and Commissioner Scott Gottlieb said the agency plans to work with product sponsors to help make the development and approval of innovative gene therapies more efficient.

To View This Article:

Login

Subscribe To Drug Industry Daily